Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

(E)-5-(2-Bromovinyl)uracil

Copy Product Info
😃Good
Catalog No. T35439Cas No. 69304-49-0

(E)-5-(2-Bromovinyl)uracil (BVU) is a pyrimidine base and an inactive metabolite of the antiviral agents sorivudine and (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU), which can be regenerated to BVDU in vivo. BVU irreversibly inactivates dihydropyrimidine dehydrogenase (DPD) in an NADPH-dependent manner, enhancing the efficacy of the chemotherapeutic agent and DPD substrate 5-fluorouracil in a P388 murine leukemia model when administered at a dose of 200 μmol/kg, thereby increasing survival time.

(E)-5-(2-Bromovinyl)uracil

(E)-5-(2-Bromovinyl)uracil

Copy Product Info
😃Good
Catalog No. T35439Cas No. 69304-49-0
(E)-5-(2-Bromovinyl)uracil (BVU) is a pyrimidine base and an inactive metabolite of the antiviral agents sorivudine and (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU), which can be regenerated to BVDU in vivo. BVU irreversibly inactivates dihydropyrimidine dehydrogenase (DPD) in an NADPH-dependent manner, enhancing the efficacy of the chemotherapeutic agent and DPD substrate 5-fluorouracil in a P388 murine leukemia model when administered at a dose of 200 μmol/kg, thereby increasing survival time.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$15835 days35 days
50 mg$26535 days35 days
100 mg$48835 days35 days
250 mg$74835 days35 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
(E)-5-(2-Bromovinyl)uracil (BVU) is a pyrimidine base and an inactive metabolite of the antiviral agents sorivudine and (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU), which can be regenerated to BVDU in vivo. BVU irreversibly inactivates dihydropyrimidine dehydrogenase (DPD) in an NADPH-dependent manner, enhancing the efficacy of the chemotherapeutic agent and DPD substrate 5-fluorouracil in a P388 murine leukemia model when administered at a dose of 200 μmol/kg, thereby increasing survival time.
Chemical Properties
Molecular Weight217.02
FormulaC6H5BrN2O2
Cas No.69304-49-0
SmilesC(=C/Br)\C=1C(=O)NC(=O)NC1
Relative Density.1.881 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMF: 60 mg/mL (276.47 mM), Sonication is recommended.
PBS (pH 7.2): 8 mg/mL (36.86 mM), Sonication is recommended.
DMSO: 53 mg/mL (244.22 mM), Sonication is recommended.
Ethanol: 0.8 mg/mL (3.69 mM), Sonication is recommended.
Solution Preparation Table
Ethanol/PBS (pH 7.2)/DMSO/DMF
1mg5mg10mg50mg
1 mM4.6079 mL23.0394 mL46.0787 mL230.3935 mL
PBS (pH 7.2)/DMSO/DMF
1mg5mg10mg50mg
5 mM0.9216 mL4.6079 mL9.2157 mL46.0787 mL
10 mM0.4608 mL2.3039 mL4.6079 mL23.0394 mL
20 mM0.2304 mL1.1520 mL2.3039 mL11.5197 mL
DMSO/DMF
1mg5mg10mg50mg
50 mM0.0922 mL0.4608 mL0.9216 mL4.6079 mL
100 mM0.0461 mL0.2304 mL0.4608 mL2.3039 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy (E)-5-(2-Bromovinyl)uracil | purchase (E)-5-(2-Bromovinyl)uracil | (E)-5-(2-Bromovinyl)uracil cost | order (E)-5-(2-Bromovinyl)uracil | (E)-5-(2-Bromovinyl)uracil chemical structure | (E)-5-(2-Bromovinyl)uracil formula | (E)-5-(2-Bromovinyl)uracil molecular weight